Article A2533

The “8 D’s” of High-Flow Nasal Cannula Risk: A Scoping Review

Author(s): Jace D. Johnny, DNP, APRN, AGACNP-BC, OCN, CCRN, Jeana Escobar, BSN, RN, CCRN, Ray Van Cao, BSN, RN, CCRN, Martin Cheehong Chow, BSN, RN, CCRN, Henry Van Slooten, BSN, RN, and Zachary Drury, DNP, APRN, AGACNP-BC, OCN, CCRN

Contact Hours 1.00

CERP A 1.00

Expires Mar 01, 2028

Topics: Pulmonary

Population: Adult

Role: APRN, Staff

Start Activity
Fees
Member: Free
NonMember: $10.00
Get CE

Added to Collection

Activity Summary

Required reading for all learners: Implicit Bias impacts patient outcomes

This scoping review is focused on exploring the risk representation in the literature for acutely ill adult patients receiving the high-flow nasal cannula (HFNC) therapy. In addition, it identified common terms used in the literature regarding the concept of deterioration for patients with HFNC.

Objectives

  • To identify the eight risks acutely ill adults encounter while receiving high-flow nasal cannula (HFNC) therapy.
  • To describe the common terms used in the literature regarding the concept of deterioration for patients with HFNC.
  • To analyze the key limitations of the scoping review and its applicability to current practice.

Continuing Education Disclosure Statement

Successful Completion

Learners must complete the entire activity and the associated evaluation to be awarded contact hours AND read Implicit Bias impacts patient outcomes. No partial credit will be awarded.

Accreditation

The American Association of Critical-Care Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Provider approved by the California Board of Registered Nursing, Provider number CEP 1036, for {contactHours} contact hours.

Disclosures

Any relevant relationship between an ineligible company and an individual with the ability to influence clinical content will be identified by the Nurse Planner within the activity. Any relevant relationship between an ineligible company and an individual with the ability to influence clinical content has been mitigated.

Accreditation refers to recognition of continuing education only and does not imply AACN, ANCC, or CBRN approval or endorsement of any commercial products discussed or displayed in conjunction with this educational activity. Activities with pharmacology hours are to assist the APRN in fulfilling the pharmacotherapeutic education requirements for licensure and certification renewals.

Activities meet the standards for most states that require mandatory continuing education for license and/or certification renewal. AACN recommends consulting with your own state board of nursing or credentialing organization before submitting your certificate of completion.

Refund Policy

Continuing Education Activities are nonrefundable.